SEC Form 4 · accession 0001225208-15-011278
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Rosenblatt
Officer — Exec V-P & Chief Med Officer
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 2, 2015 | M | 3,818 | $0.00 | A | 34,534 | D | |
| Common StockF1 | May 2, 2015 | F | 1,980 | $59.86 | D | 32,554 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $59.86 | May 1, 2015 | A | 46,440 | A | May 1, 2016 | Apr 30, 2025 | Common Stock | 46,440 | 46,440 | D |
| Restricted Stock UnitF3 | — | May 2, 2015 | M | 3,818 | D | May 2, 2015 | May 2, 2015 | Common Stock | 3,818 | 0 | D |
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.
- F2The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.
- F3Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.